Kingnet Network Co., Ltd. (SHE:002517)
China · Delayed Price · Currency is CNY 19.46
-0.09 (-0.46%)
Aug 11, 2025, 3:04 PM CST
SpringWorks Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,720 | 1,628 | 1,462 | 1,025 | 576.73 | 177.93 |
Depreciation & Amortization | 44.81 | 44.81 | 41.51 | 31.39 | 14.32 | 11.87 |
Other Amortization | 83.82 | 83.82 | 74.35 | 44.54 | 27.32 | 26.69 |
Loss (Gain) From Sale of Assets | -0.77 | -0.77 | -0.55 | 0.03 | -0.37 | 3.18 |
Asset Writedown & Restructuring Costs | -5.06 | -5.06 | 0 | -0.03 | - | 0.12 |
Loss (Gain) From Sale of Investments | 26.07 | 26.07 | -57.78 | 50.32 | -58 | -48.2 |
Provision & Write-off of Bad Debts | 7.88 | 7.88 | 1.41 | -19.15 | -30.37 | -0.17 |
Other Operating Activities | -33.73 | 1.33 | 155.05 | 333.61 | 277.3 | 51.54 |
Change in Accounts Receivable | -68.16 | -68.16 | -299.29 | -9.56 | -459.02 | 34.17 |
Change in Inventory | - | - | -9.13 | 5.69 | -12.37 | 14.87 |
Change in Accounts Payable | 46.03 | 46.03 | 336.96 | 35.5 | 137.04 | -166.75 |
Operating Cash Flow | 1,811 | 1,754 | 1,706 | 1,483 | 500.68 | 101.36 |
Operating Cash Flow Growth | 9.13% | 2.78% | 15.07% | 196.20% | 393.96% | -68.97% |
Capital Expenditures | -247.42 | -263.53 | -191 | -131.65 | -153.89 | -63.98 |
Sale of Property, Plant & Equipment | 0.68 | 0.79 | 0.52 | 0.18 | 0.83 | 1.75 |
Cash Acquisitions | - | - | - | -4.34 | - | - |
Divestitures | - | - | - | 1.04 | - | - |
Investment in Securities | -229.95 | -667.88 | -187.4 | -52.66 | 287.85 | 11.29 |
Other Investing Activities | 26.25 | 20.31 | 0.05 | 634.69 | 46.91 | 19.72 |
Investing Cash Flow | -450.44 | -910.3 | -377.83 | 447.28 | 181.69 | -31.22 |
Long-Term Debt Repaid | - | -29.69 | -20.45 | -22.26 | -10.24 | - |
Total Debt Repaid | -29.69 | -29.69 | -20.45 | -22.26 | -10.24 | - |
Net Debt Issued (Repaid) | -29.69 | -29.69 | -20.45 | -22.26 | -10.24 | - |
Issuance of Common Stock | 54.11 | 54.11 | - | 200.92 | - | 15.88 |
Repurchase of Common Stock | - | - | -199.97 | -199.97 | -100 | -100 |
Common Dividends Paid | -425.32 | -425.32 | -274.99 | - | - | - |
Other Financing Activities | -5.11 | 1.14 | -568.76 | -558.77 | -69.69 | -37.68 |
Financing Cash Flow | -406.01 | -399.77 | -1,064 | -580.08 | -179.93 | -121.81 |
Foreign Exchange Rate Adjustments | 2.39 | 2.93 | 4.2 | 19.46 | -4.58 | -9.5 |
Net Cash Flow | 956.64 | 446.68 | 268.65 | 1,370 | 497.86 | -61.17 |
Free Cash Flow | 1,563 | 1,490 | 1,515 | 1,351 | 346.79 | 37.38 |
Free Cash Flow Growth | 9.50% | -1.66% | 12.14% | 289.68% | 827.78% | -86.04% |
Free Cash Flow Margin | 30.28% | 29.12% | 35.28% | 36.27% | 14.60% | 2.42% |
Free Cash Flow Per Share | 0.74 | 0.70 | 0.71 | 0.65 | 0.16 | 0.02 |
Cash Income Tax Paid | 242.62 | 273.38 | 248.71 | 206.29 | 140.21 | 77.79 |
Levered Free Cash Flow | 1,022 | 902.81 | 856.68 | 1,382 | 28.47 | -78.58 |
Unlevered Free Cash Flow | 1,024 | 904.41 | 857.53 | 1,383 | 28.86 | -78.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.